Koppers Trades At 7x Cycle-Average Income, But All Businesses Are In Retreat

Koppers reported 3Q25 results that largely continued FY25 trends: consolidated sales fell ~12% and adjusted EBITDA declined modestly (~7.8pp), with the company trimming full-year guidance after weaker-than-expected rail demand; Performance Chemicals was the biggest hit (adj. EBITDA $26m vs $40m a year ago, residential volumes down ~20%), while RUPS posted lower sales but improved margins ($29m adj. EBITDA) and CMC contracted but marginally improved profitability. Management prioritized deleveraging over buybacks (repurchases just $4m this quarter vs $29m in 1H25), cutting net debt by $45m to $885m though leverage remains above 3x EBITDA, and expects FY CAPEX of $52–55m largely maintenance. At a market cap of ~$545m (about 7x earnings) and management EPS guidance near $4 (~$78m net income), the stock looks fairly valued on a cycle basis, but the firm maintains a Hold given peak margins, high leverage and downside risk from persistent competition and weak housing; upside would depend on a rail/utilities recovery.

Analysis

Koppers reported 3Q25 results that continued FY25 trends: consolidated sales fell roughly 12 percentage points and adjusted EBITDA declined about 7.8 percentage points, prompting management to trim full‑year guidance after weaker‑than‑expected rail demand. Performance Chemicals drove the profit decline with adjusted EBITDA down to $26 million from $40 million year‑over‑year and residential volumes down ~20% amid entry of a low‑cost competitor, though management calls this cyclical.

RUPS (Rails & Utilities) experienced sales down ~6 percentage points but improved profitability (adjusted EBITDA $29 million versus $25 million; margin ~12.5%) through cost cuts, divestments and prior pricing actions, while CMC sales fell ~16 percentage points after the phthalic anhydride closure but saw margin expansion and will be rationalized over time. PC remains the highest‑margin business (adjusted EBITDA margin ~18%) and is not being divested.

Capital allocation shifted to deleveraging: buybacks fell to $4 million this quarter from $29 million in 1H25 and net debt declined $45 million to $885 million, but leverage remains above 3x EBITDA and interest expense is ~$70 million annually; guidance implies FY CAPEX $52–55 million (≈88% maintenance). At a market cap of ~$545 million (~7x reported earnings) and management EPS guidance near $4, valuation looks fair on a normalized cycle, yet downside risk persists from peak margins, high leverage and continued competitive pressure, supporting the analyst's Hold stance.

Key Decisions for Investors

• Maintain existing positions or avoid initiating new sizeable longs until clear signs of PC competitive relief or meaningful deleveraging below ~3x EBITDA emerge, consistent with the Hold recommendation
• Monitor near‑term catalysts: Tier I rail demand trends, residential housing volumes/pricing in PC, progress on divestments and quarterly net‑debt reduction (net debt was $885m after a $45m decline), treating sustained RUPS margin improvement as the primary upside trigger
• If taking a constructive view on cyclical recovery, size new exposure conservatively and use hedges given high leverage and peak margins, while waiting for a meaningful resumption of buybacks or margin normalization before adding risk
• Avoid initiating aggressive short positions absent evidence of deeper margin compression or a deteriorating macro cycle, since current valuation (~7x earnings) already embeds cyclicality